Mercer Global Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Buy
3,900
+153
+4% +$15.7K ﹤0.01% 2577
2026
Q1
$409K Buy
3,747
+141
+4% +$13.4K ﹤0.01% 2143
2025
Q4
$292K Buy
3,606
+371
+11% +$31.9K ﹤0.01% 2249
2025
Q3
$283K Buy
3,235
+101
+3% +$9.02K ﹤0.01% 2130
2025
Q2
$260K Buy
3,134
+38
+1% +$3.18K ﹤0.01% 1931
2025
Q1
$260K Buy
3,096
+3
+0.1% +$279 ﹤0.01% 1836
2024
Q4
$285K Sell
3,093
-12
-0.4% -$1.15K ﹤0.01% 1781
2024
Q3
$282K Buy
3,105
+2
+0.1% +$173 ﹤0.01% 1644
2024
Q2
$255K Buy
3,103
+6
+0.2% +$441 ﹤0.01% 1664
2024
Q1
$206K Buy
+3,097
New +$191K ﹤0.01% 1770

Other funds holding LMAT

Mercer Global Advisors's LMAT Position: Q2 2026 in Review

Mercer Global Advisors increased its LeMaitre Vascular (LMAT) stake by 4.1% in Q2 2026, buying an estimated $15.7K and bringing the position to 3,900 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2577.

Mercer Global Advisors first reported a position in LMAT in Q1 2024 and has held it in 10 quarters since. The position peaked at $409K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Mercer Global Advisors held 3,900 shares of LeMaitre Vascular worth $374K as of Q2 2026.
  • Mercer Global Advisors bought 153 LeMaitre Vascular shares in Q2 2026, an estimated $15.7K.
  • LeMaitre Vascular made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2577 holding.
  • Mercer Global Advisors first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 10 quarters since.
  • Mercer Global Advisors's LeMaitre Vascular position peaked at $409K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.